Long-term follow-up of g 3 t 1 transitional cell carcinoma of the bladder treated with intravesical bacille calmette-guerin: 18-year experience. - Urology 2002;59:227-231.

Author： Pansadoro V.   Emiliozzi P.   de Paula F.   Scarpone P.   Pansadoro A.   Sternberg G.N.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.2, 2003-03, pp. : 165-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guerin with a reduced dose of 27mg in superficial bladder cancer. - BJU Int 2002;89:671-680.

By Martinez-Pineiro J.A.   Flores N.   Isorna S.   Solsona E.   Sebastian J.L.   Pertusa C.   Rioja L.A.   Martinez-Pineiro L.   Vela R.   Camacho J.E.   Nogueira J.L.   Pereira I.   Resel L.   Muntanola P.   Galvis F.   Chesa N.   De Torres J.A.   Carballido J.   Bernuy C.   Arribas S.   Madero R.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 169-170

Elsevier

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite

Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder - A Southwest Oncology Group Study

By Lamm D.L.   Blumenstein B.A.   Crawford E.D.   Crissman J.D.   Lowe B.A.   Smith J.A.   Sarosdy M.F.   Schellhammer P.F.   Sagalowsky A.I.   Messing E.M.   Loehrer P.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite

p53 Immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder- a helpful parameter in guiding the decision for or against cystectomy?

By Steiner G.   Bierhoff E.   Schmidt D.   Leissner J.   Wolf H.K.   Albers P.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 610-614

Elsevier

Access to resources Recommend Favorite

Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model

By Matsushima Masashi   Horinaga Minoru   Fukuyama Ryuichi   Yanaihara Hitoshi   Kikuchi Eiji   Kawachi Makoto   Iida Masahiro   Nakahira Yoko   Oya Mototsugu   Asakura Hirotaka  

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 13-19

Spandidos Publications

Access to resources Recommend Favorite